The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach
Purpose of Review
Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs.
Telemedicine for MDs has been mainly evaluated in Parkinson’s disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research.
Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.
KeywordsTelemedicine Movement disorders Telehealth Tele-education
To Drew Whalen for editorial assistance.
Telemedicine task Force Members of the International Parkinson´s disease and Movement Disorders Society
1. Bajwa J, Director, Parkinson´s, Movement Disorders and Neurorestoration National Neuroscience Institute King Fahad Medical City Riyadh, Saudi Arabia
2. Bloem BR, Radboud university medical center; Donders Institute for Brain, Cognition and Behaviour; Department of Neurology; Nijmegen, the Netherlands.
3. Galifianakis NB, Department of Neurology, University of California, San Francisco, San Francisco, California, USA.
4. Gatto E, Instituto de Neurociencias Buenos Aires, INEBA, Buenos Aires, Argentina.
5. Goetz CG, Rush University Medical Center, Chicago, IL, USA.
6. Katz M, Neurology, University of California San Francisco, San Francisco, Calif., USA.
7. Pantelyat A, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
8. Tanner C, Parkinson's Disease Research, Education and Clinical Center, Neurology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. Department of Neurology, University of California-San Francisco, San Francisco, California, USA.
9. Spindler M, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Compliance with Ethics Standards
Conflict of Interest
Browne P, Chan P, Cubo E, Guttman M, Hassan A, Hatcher JM, Moukheiber E, Okubadejo NU, Shalash A, Bajwa J, Bloem BR, Galifianakis N, Gatto E, Goetz CG, Katz M, Mari Z, Pantelyat A, Tanner C, and Spindler M declare that they have no conflict of interest.
Ben-Pazi H is the founder of NeuroCan LTD, providing accessible neurological services including teleNeurology clinics.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Institute of Medicine (US) Committee on Evaluating Clinical Applications of Telemedicine; Field MJ, editor. Telemedicine: a guide to assessing telecommunications in health care. Washington (DC): National Academies Press (US); 1996.Google Scholar
- 2.World Health Organization. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth 2009. Global Observatory for eHealth Series; 2010. pp. 2.Google Scholar
- 3.Cubo E, Doumbe J, Lopez E, et al. Telemedicine enables broader access to movement disorders curricula for medical students. Tremor Other Hyperkinet Mov (N Y). 2017;7:501.Google Scholar
- 4.Evolution and Current Applications of Telemedicine. Available from https://www.ncbi.nlm.nih.gov/books/NBK45445/).
- 9.•• Schneider RB, Biglan KM. The promise of telemedicine for chronic neurological disorders: the example of Parkinson’s disease. Lancet Neurol. 2017;16:541–51. This article describes the benefits of telemedicine for Parkinson’s disease and limitations and barriers to widespread implementation of telemedicine services remain to be addressed, including reimbursement, legal considerations, and technological issues.CrossRefPubMedGoogle Scholar
- 36.U.S. Department of Veterans Affairs. FY 2018 / FY 2016: Annual performance plan and report [online]. Available at: https://www.va.gov/budget/docs/VAapprFY2018.pdf. Accessed 15 Nov 2017.
- 37.https://mhealthintelligence.com/news/kaiser-ceo-telehealth-outpaced-in-person-visits-last-year. Visited at January 10th 2018.
- 38.Congress.gov. Medicare Telehealth Parity Act of 2017. Available at: https://www.congress.gov/bill/115th-congress/house-bill/2550/titles. Accessed 4 Dec 2017.
- 40.https://otn.ca/wp-content/uploads/2017/11/otn-annual-report.pdf. Visited at January, 10th 2018.
- 41.Li D, Zhang C, Gault J, Wang W, Liu J, Shao M, et al. Remotely programmed deep brain stimulation of the bilateral subthalamic nucleus for the treatment of primary Parkinson disease: a randomized controlled trial investigating the safety and efficacy of a novel deep brain stimulation system. Stereotact Funct Neurosurg. 2017;95:174–82.CrossRefPubMedGoogle Scholar
- 65.•• Korn RE, Shukla AW, Katz M, et al. Virtual visits for Parkinson disease: a multicenter noncontrolled cohort. Neurol Clin Pract. 2017;7:283–95. This article reports that Providing specialty care remotely into the homes of individuals with PD is feasible, but a one-time visit did not improve quality of life. Satisfaction with the visits was high among physicians and patients, who were interested in receiving such care in the future.CrossRefPubMedGoogle Scholar
- 69.Mammen JR, Elson MJ, Java JJ, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Dorsey ER Patient and physician perceptions of virtual visits for Parkinson’s disease: a qualitative study. Telemed J E Health. 2017.Google Scholar
- 70.Hassan A, Dorsey ER, Goetz CG, et al. Telemedicine task force. Telemedicine for Movement Disorders: A Global Perspective (in submission).Google Scholar
- 74.Michael J Fox Foundation (MJFF). Fox Insight Wearables: a virtual research study [online]. Available at: https://www.michaeljfox.org/fox-insight-form.html. Accessed November 8.
- 75.Mera TO, Burack MA, Giuffrida JP. Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson’s disease. J Parkinson's Dis. 2013;3:399–407.Google Scholar